Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-006865

10% owner bought 10,000 shares at $14.34 ($143,400)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2021-03-23 Purchase +10,000 $14.34 $143,400 4,798,794 D: show line 1 in the form
Open-market purchases · 10,000 sh · avg $14.34 · $143,400
Loading xslF345X03/doc1.xml…